This study will investigate the safety and efficacy of olopatadine hydrochloride / ketorolac tromethamine fixed dose combination ophthalmic solution compared with olopatadine hydrochloride ophthalmic solution in patients with seasonal allergic conjunctivitis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
129
One drop of olopatadine hydrochloride/ketorolac tromethamine fixed dose combination ophthalmic solution administered to each eye, twice daily for 21 days.
One drop of olopatadine hydrochloride 0.1% ophthalmic solution administered to each eye, twice daily for 21 days.
Unnamed facility
Bangalore, Karnataka, India
Ocular Itching
Time frame: Day 21
Hyperemia
Time frame: Day 21
Chemosis
Time frame: Day 21
Ocular mucous discharge
Time frame: Day 21
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.